Anthropic has introduced Claude 3.7 Sonnet, a frontier AI model designed to provide users with both immediate and more considered responses. The company touts it as the industry’s first “hybrid AI ...
Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced it participated in the Virtual Investor "Top 5 for ...
Sonnet BioTherapeutics Holdings, Inc. recently participated in the Virtual Investor "Top 5 for ‘25” On-Demand Conference, where CEO Pankaj Mohan, Ph.D., outlined five reasons for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results